Genes, Environment, and DNA Methylation

Total Page:16

File Type:pdf, Size:1020Kb

Genes, Environment, and DNA Methylation Epidemiologic approaches to understanding mechanisms of cardiovascular diseases: Genes, environment, and DNA methylation by Min A Jhun A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Epidemiological Science) in the University of Michigan 2015 Doctoral Committee: Assistant Professor Sung Kyun Park, Co-Chair Professor Patricia A. Peyser, Co-Chair Emeritus Professor John D. Kalbfleisch Professor Sharon L.R. Kardia Assistant Research Scientist Jennifer A. Smith © 2015 Min A Jhun All Rights Reserved Acknowledgements Heartfelt appreciation to my advisors, Dr. Patricia Peyser and Dr. Sung Kyun Park, friends, and family ii Table of Contents Acknowledgements ......................................................................................................................... ii Table of Contents ........................................................................................................................... iii List of figures ................................................................................................................................. ix List of tables ................................................................................................................................... xi List of abbreviations .................................................................................................................... xiv Abstract ....................................................................................................................................... xvii Chapter 1 Introduction .................................................................................................................... 1 Importance of Cardiovascular Disease ................................................................................... 1 Inflammation and Cardiovascular Disease ............................................................................. 2 C-reactive Protein ............................................................................................................... 3 Interleukin-6 ........................................................................................................................ 3 Interkeukin-18 ..................................................................................................................... 4 Fibrinogen ........................................................................................................................... 4 Selected Subclinical Markers of Cardiovascular Disease ....................................................... 5 Pulse Pressure and Arterial Stiffness .................................................................................. 5 Left Ventricular Ejection Fraction and Systolic Function .................................................. 6 Left Ventricular Mass Index and Hypertrophy ................................................................... 7 iii Genetics of Cardiovascular Disease........................................................................................ 8 SNPs in Cardiovascular Disease ......................................................................................... 8 DNA Methylation and Cardiovascular Disease Risks ........................................................ 9 Vitamin D, Vitamin D receptor, and Cardiovascular Disease .............................................. 10 Vitamin D and VDR ......................................................................................................... 11 VDR and Cardiovascular Disease ..................................................................................... 12 Genetics of the VDR ......................................................................................................... 13 Lead....................................................................................................................................... 13 Importance and measurement of Lead .............................................................................. 13 Lead and Cardiovascular Disease ..................................................................................... 14 Lead and VDR .................................................................................................................. 15 Mendelian Randomization .................................................................................................... 16 Two-Step Epigenetic Mendelian Randomization ............................................................. 17 Network Mendelian Randomization ................................................................................. 18 Gene by Environment Interaction in Cardiovascular Disease .............................................. 19 Overarching goal ....................................................................................................................... 19 Hypothesis for Aim 1 ............................................................................................................ 20 Hypothesis for Aim 2 ............................................................................................................ 20 Hypothesis for Aim 3 ............................................................................................................ 20 Tables ........................................................................................................................................ 22 iv References ................................................................................................................................. 23 Chapter 2 Effect modification by Vitamin D receptor genetic polymorphisms in the association between cumulative lead exposure and pulse pressure: a longitudinal study .............................. 37 Introduction ............................................................................................................................... 37 Methods..................................................................................................................................... 39 Study population ................................................................................................................... 39 Blood pressure ...................................................................................................................... 40 Lead exposure ....................................................................................................................... 40 Genotyping ............................................................................................................................ 40 Statistical analysis ................................................................................................................. 41 Results ....................................................................................................................................... 42 Discussion ................................................................................................................................. 45 Conclusion ................................................................................................................................ 50 Tables ........................................................................................................................................ 52 References ................................................................................................................................. 58 Chapter 3 Modeling the causal role of DNA methylation in the association between smoking and inflammation in African Americans ...................................................................................... 62 Introduction ............................................................................................................................... 62 Methods..................................................................................................................................... 64 Study population ................................................................................................................... 64 v Genotypes ............................................................................................................................. 65 DNA methylation .................................................................................................................. 66 Smoking variable .................................................................................................................. 66 Inflammatory markers ........................................................................................................... 67 Assumption checking ............................................................................................................ 67 Two-step epigenetic Mendelian randomization .................................................................... 69 Results ....................................................................................................................................... 73 Study population descriptive................................................................................................. 73 Assumption checking ............................................................................................................ 73 Step 1 Mendelian randomization: Smoking -> DNA methylation ....................................... 74 Step 2 Mendelian randomization: DNA methylation -> Inflammation ................................ 76 Discussion ................................................................................................................................
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Evaluation of Chromatin Accessibility in Prefrontal Cortex of Individuals with Schizophrenia
    ARTICLE DOI: 10.1038/s41467-018-05379-y OPEN Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia Julien Bryois 1, Melanie E. Garrett2, Lingyun Song3, Alexias Safi3, Paola Giusti-Rodriguez 4, Graham D. Johnson 3, Annie W. Shieh13, Alfonso Buil5, John F. Fullard6, Panos Roussos 6,7,8, Pamela Sklar6, Schahram Akbarian 6, Vahram Haroutunian 6,9, Craig A. Stockmeier 10, Gregory A. Wray3,11, Kevin P. White12, Chunyu Liu13, Timothy E. Reddy 3,14, Allison Ashley-Koch2,15, Patrick F. Sullivan 1,4,16 & Gregory E. Crawford 3,17 1234567890():,; Schizophrenia genome-wide association studies have identified >150 regions of the genome associated with disease risk, yet there is little evidence that coding mutations contribute to this disorder. To explore the mechanism of non-coding regulatory elements in schizophrenia, we performed ATAC-seq on adult prefrontal cortex brain samples from 135 individuals with schizophrenia and 137 controls, and identified 118,152 ATAC-seq peaks. These accessible chromatin regions in the brain are highly enriched for schizophrenia SNP heritability. Accessible chromatin regions that overlap evolutionarily conserved regions exhibit an even higher heritability enrichment, indicating that sequence conservation can further refine functional risk variants. We identify few differences in chromatin accessibility between cases and controls, in contrast to thousands of age-related differential accessible chromatin regions. Altogether, we characterize chromatin accessibility in the human prefrontal cortex, the effect of schizophrenia and age on chromatin accessibility, and provide evidence that our dataset will allow for fine mapping of risk variants. 1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177 Stockholm, Sweden.
    [Show full text]
  • Abstract Book
    ISSN 0390-6078 Volume 105 OCTOBER 2020 - S2 XVI Congress of the Italian Society of Experimental Hematology Napoli, Italy, October 15-17, 2020 ABSTRACT BOOK www.haematologica.org XVI Congress of the Italian Society of Experimental Hematology Napoli, Italy, October 15-17, 2020 COMITATO SCIENTIFICO Pellegrino Musto, Presidente Antonio Curti, Vice Presidente Mario Luppi, Past President Francesco Albano Niccolò Bolli Antonella Caivano Roberta La Starza Luca Malcovati Luca Maurillo Stefano Sacchi SEGRETERIA SIES Via De' Poeti, 1/7 - 40124 Bologna Tel. 051 6390906 - Fax 051 4210174 e-mail: [email protected] www.siesonline.it SEGRETERIA ORGANIZZATIVA Studio ER Congressi Via De' Poeti, 1/7 - 40124 Bologna Tel. 051 4210559 - Fax 051 4210174 e-mail: [email protected] www.ercongressi.it ABSTRACT BOOK supplement 2 - October 2020 Table of Contents XVI Congress of the Italian Society of Experimental Hematology Napoli, Italy, October 15-17, 2020 Main Program . 1 Best Abstracts . 20 Oral Communications Session 1. C001-C008 Acute Leukemia 1 . 23 Session 2. C009-C016 Chronic Lymphocytic Leukemia 1 . 28 Session 3. C017-C024 Multiple Myeloma 1 . 32 Session 4. C025-C032 Benign Hematology . 36 Session 5. C033-C040 Multiple Myeloma 2 . 42 Session 6. C041-C048 Acute Leukemia 2 . 45 Session 7. C049-C056 Molecular Hematology . 50 Session 8. C057-C064 Lymphomas. 54 Session 9. C065-C072 Chronic Lymphocytic Leukemia 2 . 57 Session 10. C073-C080 Myelodisplastic Syndromes and Acute Leukemia . 62 Session 11. C081-C088 Myeloproliferative Disorders and Chronic Myeloid Leukemia . 66 Session 12. C089-C096 Stem Cell Transplantation. 71 Posters Session 1. P001 Stem cells and growth factors .
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • Epigenetic Services Citations
    Active Motif Epigenetic Services Publications The papers below contain data generated by Active Motif’s Epigenetic Services team. To learn more about our services, please give us a call or visit us at www.activemotif.com/services. Technique Target Journal Year Reference Justin C. Boucher et al. CD28 Costimulatory Domain- ATAC-Seq, Cancer Immunol. Targeted Mutations Enhance Chimeric Antigen Receptor — 2021 RNA-Seq Res. T-cell Function. Cancer Immunol. Res. doi: 10.1158/2326- 6066.CIR-20-0253. Satvik Mareedu et al. Sarcolipin haploinsufficiency Am. J. Physiol. prevents dystrophic cardiomyopathy in mdx mice. RNA-Seq — Heart Circ. 2021 Am J Physiol Heart Circ Physiol. doi: 10.1152/ Physiol. ajpheart.00601.2020. Gabi Schutzius et al. BET bromodomain inhibitors regulate Nature Chemical ChIP-Seq BRD4 2021 keratinocyte plasticity. Nat. Chem. Biol. doi: 10.1038/ Biology s41589-020-00716-z. Siyun Wang et al. cMET promotes metastasis and ChIP-qPCR FOXO3 J. Cell Physiol. 2021 epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP. J. Cell Physiol. doi: 10.1002/jcp.30142. Sonia Iyer et al. Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of ATAC-Seq — Cancer Discovery 2021 Combination Immunotherapy. Cancer Discov. doi: doi: 10.1158/2159-8290 Vinod Krishna et al. Integration of the Transcriptome and Genome-Wide Landscape of BRD2 and BRD4 Binding BRD2, BRD4, RNA Motifs Identifies Key Superenhancer Genes and Reveals ChIP-Seq J. Immunol. 2021 Pol II the Mechanism of Bet Inhibitor Action in Rheumatoid Arthritis Synovial Fibroblasts. J. Immunol. doi: doi: 10.4049/ jimmunol.2000286. Daniel Haag et al.
    [Show full text]
  • Functional Annotation of Human Long Noncoding Rnas Using Chromatin
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.13.426305; this version posted January 14, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Funconal annotaon of human long noncoding RNAs using chroman conformaon data Saumya Agrawal1, Tanvir Alam2, Masaru Koido1,3, Ivan V. Kulakovskiy4,5, Jessica Severin1, Imad ABugessaisa1, Andrey Buyan5,6, Josee Dos&e7, Masayoshi Itoh1,8, Naoto Kondo9, Yunjing Li10, Mickaël Mendez11, Jordan A. Ramilowski1,12, Ken Yagi1, Kayoko Yasuzawa1, CHi Wai Yip1, Yasushi Okazaki1, MicHael M. Ho9man11,13,14,15, Lisa Strug10, CHung CHau Hon1, CHikashi Terao1, Takeya Kasukawa1, Vsevolod J. Makeev4,16, Jay W. SHin1, Piero Carninci1, MicHiel JL de Hoon1 1RIKEN Center for Integra&ve Medical Sciences, YokoHama, Japan. 2College of Science and Engineering, Hamad Bin KHalifa University, DoHa, Qatar. 3Ins&tute of Medical Science, THe University of Tokyo, Tokyo, Japan. 4Vavilov Ins&tute of General Gene&cs, Russian Academy of Sciences, Moscow, Russia. 5Ins&tute of Protein ResearcH, Russian Academy of Sciences, PusHcHino, Russia. 6Faculty of Bioengineering and Bioinforma&cs, Lomonosov Moscow State University, Moscow, Russia. 7Department of BiocHemistry, Rosalind and Morris Goodman Cancer ResearcH Center, McGill University, Montréal, QuéBec, Canada. 8RIKEN Preven&ve Medicine and Diagnosis Innova&on Program, Wako, Japan. 9RIKEN Center for Life Science TecHnologies, YokoHama, Japan. 10Division of Biosta&s&cs, Dalla Lana ScHool of PuBlic HealtH, University of Toronto, Toronto, Ontario, Canada. 11Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. 12Advanced Medical ResearcH Center, YokoHama City University, YokoHama, Japan.
    [Show full text]
  • In Silco Study of MIR-124-1 Transcription Factors in Glioblastoma
    Journal of Pharmaceutical Research International 33(12): 71-83, 2021; Article no.JPRI.65792 ISSN: 2456-9119 (Past name: British Journal of Pharmaceutical Research, Past ISSN: 2231-2919, NLM ID: 101631759) In Silco Study of MIR-124-1 Transcription Factors in Glioblastoma Khloud M. Algothmi1* 1Department of Biology, King Abdulaziz University, Jedda, Saudi Arabia. Author’s contribution The sole author designed, analysed, interpreted and prepared the manuscript. Article Information DOI: 10.9734/JPRI/2021/v33i1231257 Editor(s): (1) Dr. Arun Singh, Rohilkhand Medical College and Hospital, India. Reviewers: (1) Dewa Putu Wisnu Wardhana, Udayana University, Indonesia. (2) Xiaodong Li, The Third Affiliated Hospital of Soochow University, P. R. China. Complete Peer review History: http://www.sdiarticle4.com/review-history/65792 Received 20 December 2020 Original Research Article Accepted 23 February 2021 Published 17 March 2021 ABSTRACT MIR-124-1 is a brain-abundant MIRNA, whose expression is important for neuronal tissue division, growth and actions. However, expression of miR-124-1 regulatory mechanisms controlling its actions in neuronal cells in health and diseases still poorly addressed. To understand mechanism for transcriptional and functional regulation of miR-124 in neuronal and glioblastoma cells, this study combined gene expression profiling data and computational transcription factor and microRNA target predictions. The present research focuses on transcription factors and DNA methylation, which are central to miR-124-1 expression regulation. A core promoter sequence of miR-124-1 was predicted to be 500 bp and 100 bp, upstream and downstream of its transcription start sites. Seventy three binding sites of fifty transcription factors in promoter region were found, using MatInspector software.
    [Show full text]
  • Transcriptomic Regulation of Alternative Phenotypic Trajectories in Embryos of the Annual Killifish Austrofundulus Limnaeus
    Portland State University PDXScholar Dissertations and Theses Dissertations and Theses Fall 11-30-2017 Transcriptomic Regulation of Alternative Phenotypic Trajectories in Embryos of the Annual Killifish Austrofundulus limnaeus Amie L. Romney Portland State University Follow this and additional works at: https://pdxscholar.library.pdx.edu/open_access_etds Part of the Biology Commons, and the Genetics and Genomics Commons Let us know how access to this document benefits ou.y Recommended Citation Romney, Amie L., "Transcriptomic Regulation of Alternative Phenotypic Trajectories in Embryos of the Annual Killifish Austrofundulus limnaeus" (2017). Dissertations and Theses. Paper 4033. https://doi.org/10.15760/etd.5917 This Dissertation is brought to you for free and open access. It has been accepted for inclusion in Dissertations and Theses by an authorized administrator of PDXScholar. Please contact us if we can make this document more accessible: [email protected]. Transcriptomic Regulation of Alternative Phenotypic Trajectories in embryos of the Annual Killifish Austrofundulus limnaeus by Amie Lynn Thomas Romney A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biology Dissertation Committee Jason Podrabsky, Chair Suzanne Estes Bradley Buckley Todd Rosenstiel Dirk Iwata-Reuyl Portland State University 2017 © 2017 Amie Lynn Thomas Romney ABSTRACT The Annual Killifish, Austrofundulus limnaeus, survives the seasonal drying of their pond habitat in the form of embryos entering diapause midway through development. The diapause trajectory is one of two developmental phenotypes. Alternatively, individuals can “escape” entry into diapause and develop continuously until hatching. The alternative phenotypes of A. limnaeus are a form of developmental plasticity that provides this species with a physiological adaption for surviving stressful environments.
    [Show full text]
  • Functional Analysis of Haplotypes and Promoter Activity at the 5' Region of the ADH7 Gene
    Functional Analysis of Haplotypes and Promoter Activity at the 5’ Region of the ADH7 Gene Kuo Zeng Institute of Forensic Medicine Ya Li Institute of Forensic Medicine Meng Gao Institute of Forensic Medicine Yong-ping Liu Institute of Forensic Medicine Feng-ling Xu Institute of Forensic Medicine Xi Xia Institute of Forensic Medicine Jun Yao Institute of Forensic Medicine baojie Wang ( [email protected] ) Institute of Forensic Medicine https://orcid.org/0000-0003-1931-423X Original Research Keywords: ADH7, Haplotype, Promoter region, Transcriptional regulation, Gene expression Posted Date: February 4th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-157005/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/12 Abstract Background: The function of the 5’ regulatory region and the role of the different SNP loci have not been well characterized. This study investigated the effect of several ADH7 haplotypes on the regulation of gene expression in vitro and the functional sequences in the 5’ regulatory region of ADH7. Three SNPs (rs17537595, rs2851028, and rs2654847) and four different haplotypes (T-C-T, T-T-T, C-T-T, T-C-A) were identied by cloning and sequencing. Methods: Effects of 4 different haplotypes and 8 truncated fragments of 5’ regulatory region on ADH7 gene expression were detected using a dual-luciferase reporter assay system. All recombinant plasmids were transfected into HEK-293, U87, and SH-SY5Y cells, respectively, and their relative uorescence intensity was measured. Results: In HEK-293, U87, and SH-SY5Y cell lines, the relative uorescence intensity of haplotype T-C-T was signicantly higher than that of haplotype T-T-T, C-T-T, and T-C-A.
    [Show full text]
  • Targeted Sequence Capture and Ultra High Throughput Sequencing for Gene Discovery in Inherited Diseases
    Unicentre CH-1015 Lausanne http://serval.unil.ch Year : 2013 Targeted sequence capture and Ultra High Throughput sequencing for gene discovery in inherited diseases Dl GIOIA SILVIO ALESSANDRO Dl GIOIA SILVIO ALESSANDRO, 2013, Targeted sequence capture and Ultra High Throughput sequencing for gene discovery in inherited diseases Originally published at : Thesis, University of Lausanne Posted at the University of Lausanne Open Archive. http://serval.unil.ch Droits d’auteur L'Université de Lausanne attire expressément l'attention des utilisateurs sur le fait que tous les documents publiés dans l'Archive SERVAL sont protégés par le droit d'auteur, conformément à la loi fédérale sur le droit d'auteur et les droits voisins (LDA). A ce titre, il est indispensable d'obtenir le consentement préalable de l'auteur et/ou de l’éditeur avant toute utilisation d'une oeuvre ou d'une partie d'une oeuvre ne relevant pas d'une utilisation à des fins personnelles au sens de la LDA (art. 19, al. 1 lettre a). A défaut, tout contrevenant s'expose aux sanctions prévues par cette loi. Nous déclinons toute responsabilité en la matière. Copyright The University of Lausanne expressly draws the attention of users to the fact that all documents published in the SERVAL Archive are protected by copyright in accordance with federal law on copyright and similar rights (LDA). Accordingly it is indispensable to obtain prior consent from the author and/or publisher before any use of a work or part of a work for purposes other than personal use within the meaning of LDA (art. 19, para.
    [Show full text]
  • Xo PANEL DNA GENE LIST
    xO PANEL DNA GENE LIST ~1700 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes (at 400 -500x average coverage on tumor) Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11
    [Show full text]
  • Zytolight ® SPEC ZNF384 Dual Color Break Apart Probe
    ZytoLight ® SPEC ZNF384 Dual Color Break Apart Probe Background Probe Description Results The ZytoLight ® SPEC ZNF384 Dual Color The SPEC ZNF384 Dual Color Break In an interphase nucleus lacking a translo- Break Apart Probe is designed to detect Apart Probe is a mixture of two direct la- cation involving the 12p13.31 band, two translocations involving the chromosomal beled probes hybridizing to the 12p13.31 orange/green fusion signals are expected, region 12p13.31 harboring the ZNF384 band. The orange fluorochrome direct representing two normal (non-rearranged) gene. labeled probe hybridizes proximal to the 12p13.31 loci. A signal pattern consisting The ZNF384 (zinc-finger protein 384, ZNF384 gene, the green fluorochrome of one orange/green fusion signal, one a.k.a. CIZ) gene encodes a transcription direct labeled probe hybridizes distal to orange signal, and a separate green sig- factor involved in the regulation of matrix the ZNF384 gene. nal indicates one normal 12p13.31 locus metalloproteinases. and one 12p13.31 locus affected by a ZNF384 Rearrangements of the ZNF384 gene are ZNF384 translocation. recurrent in acute leukemia and are most frequently found in precursor B-cell acute lymphoblastic leukemia (BCP-ALL) in chil- dren and young adults with an incidence of about 3-4%. ZNF384-related fusion genes with multiple fusion partners have Ideogram of chromosome 12 been found to define a distinct subgroup indicating the hybridization locations. of pediatric BCP-ALL with a characteristic RH106101 RH39803 immunophenotype. Known translocation RH52677 RH102330 3’ 5’ partners are TCF3 (19p13.3), EWSR1 (22q12.2), TAF15 (17q12), EP300 ZNF384 (22q13.2), ARID1B (6q25.3), ~755 kb ~380 kb Tel 12p13.31 Cen CREBBP (16p13.3), and BMP2K SPEC ZNF384 Dual Color Break Apart Probe (4q21.21) with TCF3 being the most prev- SPEC ZNF384 Probe map (not to scale).
    [Show full text]